Immunome, Inc.
IL-38-SPECIFIC ANTIBODIES

Last updated:

Abstract:

This invention relates to antibodies specific for human interleukin-38 (IL-38), including isolated antibodies, or antigen-binding fragments thereof. The antibodies, or antigen-binding fragments thereof, described here partially or fully block, inhibit, or neutralize a biological activity of IL 38. Methods described here relate to inhibiting tumor growth or metastasis in an individual afflicted by tumor growth and/or metastasis.

Status:
Application
Type:

Utility

Filling date:

30 Jul 2020

Issue date:

1 Sep 2022